Atlas Trials

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Clinical trial NCT05569148 · COMPLETED

Trial details

NCT number
NCT05569148
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Start date
2022-10-17
Primary completion
2022-11-10
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.